These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Endoscopic ultrasound restaging after neoadjuvant chemotherapy in esophageal cancer. Ribeiro A; Franceschi D; Parra J; Livingstone A; Lima M; Hamilton-Nelson K; Ardalan B Am J Gastroenterol; 2006 Jun; 101(6):1216-21. PubMed ID: 16771940 [TBL] [Abstract][Full Text] [Related]
10. Comparative study between endoscopic ultrasonography and positron emission tomography-computed tomography in staging patients with esophageal squamous cell carcinoma. Yen TJ; Chung CS; Wu YW; Yen RF; Cheng MF; Lee JM; Hsu CH; Chang YL; Wang HP Dis Esophagus; 2012 Jan; 25(1):40-7. PubMed ID: 21595776 [TBL] [Abstract][Full Text] [Related]
11. Endoscopic ultrasound: doubtful accuracy for restaging esophageal cancer after preoperative chemotherapy. Machlenkin S; Melzer E; Idelevich E; Ziv-Sokolovsky N; Klein Y; Kashtan H Isr Med Assoc J; 2009 Mar; 11(3):166-9. PubMed ID: 19544707 [TBL] [Abstract][Full Text] [Related]
12. Pretreatment staging by endoscopic ultrasonography does not predict complete response to neoadjuvant chemoradiation in patients with esophageal carcinoma. Mallery S; DeCamp M; Bueno R; Mentzer SJ; Sugarbaker DJ; Swanson SJ; Van Dam J Cancer; 1999 Sep; 86(5):764-9. PubMed ID: 10463973 [TBL] [Abstract][Full Text] [Related]
13. Prospective, open, multicentre Phase I/II trial to assess safety and efficacy of neoadjuvant radiochemotherapy with docetaxel and cisplatin for esophageal carcinoma. Ma HB; Di ZL; Wen J; Ke Y; Sun X; Ren J Jpn J Clin Oncol; 2015 Feb; 45(2):169-75. PubMed ID: 25416813 [TBL] [Abstract][Full Text] [Related]
14. Effects of neoadjuvant radiochemotherapy on pathological staging and prognosis for locally advanced esophageal squamous cell carcinoma. Cao XF; He XT; Ji L; Xiao J; Lv J Dis Esophagus; 2009; 22(6):477-81. PubMed ID: 19703071 [TBL] [Abstract][Full Text] [Related]
15. Response evaluation by endoscopy, rebiopsy, and endoscopic ultrasound does not accurately predict histopathologic regression after neoadjuvant chemoradiation for esophageal cancer. Schneider PM; Metzger R; Schaefer H; Baumgarten F; Vallbohmer D; Brabender J; Wolfgarten E; Bollschweiler E; Baldus SE; Dienes HP; Hoelscher AH Ann Surg; 2008 Dec; 248(6):902-8. PubMed ID: 19092334 [TBL] [Abstract][Full Text] [Related]
16. Refining pathological evaluation of neoadjuvant therapy for adenocarcinoma of the esophagus. Noble F; Nolan L; Bateman AC; Byrne JP; Kelly JJ; Bailey IS; Sharland DM; Rees CN; Iveson TJ; Underwood TJ; Bateman AR World J Gastroenterol; 2013 Dec; 19(48):9282-93. PubMed ID: 24409055 [TBL] [Abstract][Full Text] [Related]
17. Downstaging of T or N predicts long-term survival after preoperative chemotherapy and radical resection for esophageal carcinoma. Korst RJ; Kansler AL; Port JL; Lee PC; Kerem Y; Altorki NK Ann Thorac Surg; 2006 Aug; 82(2):480-4; discussion 484-5. PubMed ID: 16863749 [TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant chemoradiation versus chemotherapy for patients undergoing esophagectomy for esophageal cancer. Luu TD; Gaur P; Force SD; Staley CA; Mansour KA; Miller JI; Miller DL Ann Thorac Surg; 2008 Apr; 85(4):1217-23; discussion 1223-4. PubMed ID: 18355499 [TBL] [Abstract][Full Text] [Related]
19. The accuracy of endoscopic ultrasound for restaging esophageal carcinoma after chemoradiation therapy. Kalha I; Kaw M; Fukami N; Patel M; Singh S; Gagneja H; Cohen D; Morris J Cancer; 2004 Sep; 101(5):940-7. PubMed ID: 15329901 [TBL] [Abstract][Full Text] [Related]
20. Endoscopic ultrasound does not accurately assess pathologic stage of esophageal cancer after neoadjuvant chemoradiotherapy. Beseth BD; Bedford R; Isacoff WH; Holmes EC; Cameron RB Am Surg; 2000 Sep; 66(9):827-31. PubMed ID: 10993609 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]